Companies List
>> Allergan
Allergan, Inc. is a global healthcare company that discovers and develops specialty pharmaceutical and medical device products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention and other specialty markets. It provides specialty pharmaceutical research, targeting products and technologies related to specific disease areas, such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders. Allergan, Inc. discovers, develops and markets medical devices, aesthetics-related pharmaceuticals and over-the-counter products. The Company is focusing research and development efforts on therapeutic areas, including gastroenterology, neuropathic pain and genitourinary diseases.
Official website:
www.allergan.com
|
|
 |
|
USA stock market daily report by Millenium Traders (October 6, 2008, Monday, 10.30 p.m. GMT), 6 October 2008
USA stock market daily report by Millenium Traders (October 3, 2008, Friday, 10.30 p.m. GMT), 3 October 2008
USA stock market daily report by Millenium Traders (October 2, 2008, Thursday, 10.30 p.m. GMT), 2 October 2008
|
|
Verint Systems price target reduced, 7 December 2007
Thomas Weisel upgraded Intel to "overweight", 6 December 2007
UBS upgraded price target on Exxon Mobil to $96, 21 November 2007
|
|
|
|
|
|
 |
|
Indian stock market morning report by Keynote Capitals (October 7, 2008, Tuesday, 6.00 a.m. GMT), 7 October 2008
Indian stock market morning report by Keynote Capitals (October 6, 2008, Monday, 6.00 a.m. GMT), 6 October 2008
Indian stock market morning report by Keynote Capitals (October 3, 2008, Friday, 6.00 a.m. GMT), 3 October 2008
|
|
Keynote Capitals maintain "buy" recommendation on Pyramid Saimira Theatre, 5 February 2008
Keynote Capitals recommends to buy Euro Ceramics Ltd., 5 February 2008
Keynote Capitals recommends to buy Pyramid Saimira Theatre, 13 December 2007
|
|
|
|
|
|
 |
|
Russian stock market morning report by Veles Capital (October 7, 2008, Tuesday, 7.30 a.m. GMT), 7 October 2008
Russian stock market morning report by Veles Capital (October 6, 2008, Monday, 7.30 a.m. GMT), 6 October 2008
Russian stock market morning report by Veles Capital (October 3, 2008, Thursday, 7.30 a.m. GMT), 3 October 2008
|
|
Veles Capital upgraded price target on Rosneft from $14.31 to $15.11, recommendation "buy" unchanged, 18 September 2008
Veles Capital set price target of $5.75 on NLMK, recommenation - "buy", 17 September 2008
Veles Capital reduced price target on Lukoil from $138.44 to $129.63, recommendation "buy" unchanged, 15 September 2008
|
|
|
|
|
|
